Sponsor Pipeline

Axovia Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-05 NCT07269665
First-in-Human, Dose Escalation Trial of AXV-101 in BBS1-Related Retinal Degeneration		 Recruitment opened
Active Trials by Phase
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Early Phase 1
NCT07269665 First-in-Human, Dose Escalation Trial of AXV-101 in BBS1-Related Retinal Degeneration Bardet-Biedl Syndrome 1 Recruiting
Get alerts when Axovia Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free